Terms: = Liver cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Treatment
19 results:
1. dnmt3a Cooperates with YAP/TAZ to Drive Gallbladder cancer Metastasis.
Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
[TBL] [Abstract] [Full Text] [Related]
2. NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression.
Sun GF; Ding H
Neoplasma; 2023 Jun; 70(3):340-349. PubMed ID: 37498063
[TBL] [Abstract] [Full Text] [Related]
3. SPATS2 is positively activated by long noncoding RNA SNHG5 via regulating dnmt3a expression to promote hepatocellular carcinoma progression.
Yan J; Huang QY; Huang YJ; Wang CS; Liu PX
PLoS One; 2022; 17(1):e0262262. PubMed ID: 35077478
[TBL] [Abstract] [Full Text] [Related]
4. Exposure to glyphosate and tetrachlorvinphos induces cytotoxicity and global DNA methylation in human cells.
Ergun H; Cayir A
Toxicol Ind Health; 2021 Oct; 37(10):610-618. PubMed ID: 34542374
[TBL] [Abstract] [Full Text] [Related]
5. Activation of DNA methyltransferase 3a by Epstein-Barr nuclear antigen 1 in gastric carcinoma.
Song H; Zhang Y; Liu J; Liu W; Luo B
Dig Liver Dis; 2022 Jul; 54(7):973-983. PubMed ID: 34215536
[TBL] [Abstract] [Full Text] [Related]
6. Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma.
Patrinely JR; Johnson R; Lawless AR; Bhave P; Sawyers A; Dimitrova M; Yeoh HL; Palmeri M; Ye F; Fan R; Davis EJ; Rapisuwon S; Long GV; Haydon A; Osman I; Mehnert JM; Carlino MS; Sullivan RJ; Menzies AM; Johnson DB
JAMA Oncol; 2021 May; 7(5):744-748. PubMed ID: 33764387
[TBL] [Abstract] [Full Text] [Related]
7. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
[TBL] [Abstract] [Full Text] [Related]
8. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
[TBL] [Abstract] [Full Text] [Related]
9. Squalene epoxidase drives NAFLD-induced hepatocellular carcinoma and is a pharmaceutical target.
Liu D; Wong CC; Fu L; Chen H; Zhao L; Li C; Zhou Y; Zhang Y; Xu W; Yang Y; Wu B; Cheng G; Lai PB; Wong N; Sung JJY; Yu J
Sci Transl Med; 2018 Apr; 10(437):. PubMed ID: 29669855
[TBL] [Abstract] [Full Text] [Related]
10. MiR-30b-5p acts as a tumor suppressor, repressing cell proliferation and cell cycle in human hepatocellular carcinoma.
Qin X; Chen J; Wu L; Liu Z
Biomed Pharmacother; 2017 May; 89():742-750. PubMed ID: 28273636
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of MiR-34 Family and DNA Methyltransferases 1, 3A, 3B Gene Expression Levels in Hepatocellular Carcinoma Following treatment with Dendrosomal Nanocurcumin.
Chamani F; Sadeghizadeh M; Masoumi M; Babashah S
Asian Pac J Cancer Prev; 2016; 17(S3):219-24. PubMed ID: 27165229
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-200b inhibits the proliferation of hepatocellular carcinoma by targeting DNA methyltransferase 3a.
Li XY; Feng XZ; Tang JZ; Dong K; Wang JF; Meng CC; Wang J; Mo YW; Sun ZW
Mol Med Rep; 2016 May; 13(5):3929-35. PubMed ID: 26986232
[TBL] [Abstract] [Full Text] [Related]
13. Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer.
Zamani M; Sadeghizadeh M; Behmanesh M; Najafi F
Phytomedicine; 2015 Sep; 22(10):961-7. PubMed ID: 26321746
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
[TBL] [Abstract] [Full Text] [Related]
15. Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.
Miranda E; Bianchi P; Destro A; Morenghi E; Malesci A; Santoro A; Laghi L; Roncalli M
Cancer; 2013 Jan; 119(2):266-76. PubMed ID: 22786759
[TBL] [Abstract] [Full Text] [Related]
16. A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.
Datta J; Ghoshal K; Denny WA; Gamage SA; Brooke DG; Phiasivongsa P; Redkar S; Jacob ST
Cancer Res; 2009 May; 69(10):4277-85. PubMed ID: 19417133
[TBL] [Abstract] [Full Text] [Related]
17. Preoperative chemoembolization of hepatocellular carcinoma: a comparative study.
Paye F; Jagot P; Vilgrain V; Farges O; Borie D; Belghiti J
Arch Surg; 1998 Jul; 133(7):767-72. PubMed ID: 9688007
[TBL] [Abstract] [Full Text] [Related]
18. Selective tumor irradiation by infusional brachytherapy in nonresectable pancreatic cancer: a phase I study.
Order SE; Siegel JA; Principato R; Zeiger LE; Johnson E; Lang P; Lustig R; Wallner PE
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1117-26. PubMed ID: 8985034
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of retinoid toxicity by rat liver S9 fraction in cultured mammalian cells.
Qin S; Sirianni SR; Huang CC
Cancer Lett; 1983 Dec; 21(2):201-10. PubMed ID: 6686081
[TBL] [Abstract] [Full Text] [Related]
